COVID-19 - ImmPort

image

Image CDC Coronavirus Disease 2019 – COVID 19, Alissa Eckert



Coronavirus Disease 19

Powered by ImmPort


The COVID-19 pandemic is growing exponentially. ImmPort presents an opportunity to leverage legacy studies on infectious diseases, including Influenza (over 100 studies) and other respiratory-like illnesses from diverse cohorts (e.g. age, race, gender) sourced from NIAID-sponsored programs and beyond. If you are interested in sharing your COVID research data through ImmPort please contact ImmPort_COVID19. The ImmPort team’s curation staff can provide assistance and guidance for data curation, loading and sharing.


Disease type Assays
COVID-19 studies

ELISA

Influenza studies

ELISA, ELISPOT, Flow Cytometry, HAI

Respiratory-like illness studies

Flow cytometry, CyToF, RNA-seq, Transcription Profiling by Array

Viral infectious disease studies

ELISA, ELISPOT, Flow cytometry, CyToF, HLA-Typing, RNA-seq, Transcription Profiling by Array

COVID-19 new studies

ELISA, ELISPOT, Flow cytometry, CyToF, HLA-Typing, RNA-seq, Transcription Profiling by Array



The 10,000 Immunomes Project is a reference dataset for human immunology, derived from over 10,000 control subjects in the NIAID ImmPort Database.

Download ImmPort data: Application Program Interface to query the shared data and download result files.